Pharma Sector Overview
| Piramal Pharma Ltd. | -0.08% | -3.08% | 132.23% | 6.13% | 9.02% | 13.32% | -106.03% | -456.52% | -0.32% | -3.67% | 23,009.32 Cr |
| Granules India Ltd. | 22.81% | 19.73% | 5.95% | 26.70% | 22.09% | 17.50% | 31.26% | 18.27% | 13.71% | 11.09% | 21,583.12 Cr |
Pharma Sector Summary
Revenue Growth (YoY)
8.55%
Average ROE
N/A
Average ROCE
N/A
EBITDA Margin
13.88%
PAT Margin
4.97%
EBITDA Margin (3Y)
N/A
PAT Margin (3Y)
N/A
Total Companies
2
* Q3 represents quarterly (latest quarter) data comparison
* 1 Y represents yearly comparison
* 3 Y represents 3-year rolling average
* TTM represents Trailing Twelve Months
* CAGR represents Compound Annual Growth Rate over 3 years
* M.Cap represents Market Capitalization
* P/E represents Price to Earnings ratio
* P/S represents Price to Sales ratio
* P/BV represents Price to Book Value ratio
* EV/EBITDA represents Enterprise Value to EBITDA ratio
* ROE represents Return on Equity
* ROCE represents Return on Capital Employed
* ROA represents Return on Assets
* All financial figures are in INR
* N/A indicates data not available or not applicable